id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-D-2899-0013,FDA,FDA-2022-D-2899,Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs; Guidance for Industry; Availability,Notice,Notice of Availability,2024-06-26T04:00:00Z,2024,6,2024-06-26T04:00:00Z,,2024-06-26T13:10:31Z,2024-13922,0,0,09000064865c9e3b
FDA-2022-D-2899-0014,FDA,FDA-2022-D-2899,Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs; Guidance for Industry,Other,Guidance,2024-06-26T04:00:00Z,2024,6,2024-06-26T04:00:00Z,,2024-11-12T22:37:53Z,,1,0,09000064865c9ff8